Home | Sitemap | Contact Us | Login   
Announcements

Quick Search Article: Category:

There are 27 records that matched your search criteria (sorted by : DESC order)
Date Title Category
14-Sep-2009 Caution Statement on “Potential for an Increase in Risk of Suicidal Thoughts or Behaviours” required to be included in the product package insert for Antiepileptik.
Bil (43) dlm. BPFK/PPP/01/03 dated 14th Sept 2009
DCA letters
14-Sep-2009 Caution Statement on “Possible Interaction between Clopidogrel and Proton Pump Inhibitors” required to be included in the product package insert for Clopidogrel
Bil (42) dlm. BPFK/PPP/01/03 dated 14th Sept 2009
DCA letters
14-Sep-2009 Caution Statement on “Potential For an increase in risk of Hepatotoxicity” required to be included in the product package insert for Propylthiouracil
Bil (41) dlm. BPFK/PPP/01/03 dated 14th Sept 2009
DCA letters
14-Sep-2009 Caution Statement on “Potential For an increase in risk of Hepatotoxicity” required to be included in the product package insert for Propylthiouracil
Bil (41) dlm. BPFK/PPP/01/03 dated 14th Sept 2009
DCA letters
14-Jun-2011 Joint MyIPO-PhAMA Seminar on '1 Malaysia Medicines: The Way Forward in Intellectual Property'
MyIPO Office, Level 12A, Menara UOA, Jalan Bangsar Utama 1, Bangsar, Kuala Lumpur
14-Jun-2011 MyIPO-PhAMA IP Seminar on Intellectual Property: 'The Way Forward' - Post event Videos and Photos
The MyIPO-PhAMA IP Seminar on Intellectual Property: "The Way Forward", was held on Tuesday 14 June 2011 at the...
24-Mar-2016 44th PhAMA Annual General Meeting 2016

Previous | 1 | 2

21 - 27 of 27 results